Cancer

New treatment for non-Hodgkin lymphoma approved

(HealthDay)—Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two types of non-Hodgkin lymphoma.

Cancer

Attacking lymphoma at the source

Non-Hodgkin lymphomas are cancers that affect white blood cells of the immune system called B-lymphocytes, or B cells. Like cells in all cancers, the B cells begin to grow out of control, creating tumors in the lymph nodes, ...

Immunology

The STING of death in T cells

The cells of the innate immune system use a signaling pathway comprising STING (Stimulator of interferon genes) to detect DNA from invading viruses and fight them. However, it is unknown if STING triggers the same or different ...

Medical research

3-D organoids allow tests of lymphoma treatments

Cornell researchers have engineered a 3-D lymphoma organoid – a tissue culture that mimics the complex environment of lymphomas allowing scientists to study non-Hodgkin lymphomas – a technology that promises to rapidly ...

page 1 from 5